Co‐occurrence of fecal incontinence with constipation or irritable bowel syndrome indicates the need for personalized treatment

Background This study aimed to compare the prevalence and symptoms of fecal incontinence (FI) in relation to irritable bowel syndrome (IBS‐associated FI), constipation (constipation‐associated FI), and isolation (isolated FI). Methods Data were analyzed from 3145 respondents without organic comorbid...

Full description

Saved in:
Bibliographic Details
Published in:Neurogastroenterology and motility 2023-09, Vol.35 (9), p.e14633-n/a
Main Authors: Sun, Ge, Trzpis, Monika, Ding, Haibo, Gao, Xianhua, Broens, Paul M. A., Zhang, Wei
Format: Article
Language:English
Subjects:
Comorbidity
Constipation
co‐occurrence
Defecation
diagnosis
Diarrhea
Fecal incontinence
Feces
Intestine
Irritable bowel syndrome
Pain
personalized treatment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background This study aimed to compare the prevalence and symptoms of fecal incontinence (FI) in relation to irritable bowel syndrome (IBS‐associated FI), constipation (constipation‐associated FI), and isolation (isolated FI). Methods Data were analyzed from 3145 respondents without organic comorbidities known to influence defecation function from the general Chinese population who filled in the online Groningen Defecation and Fecal Continence questionnaire. FI, IBS, and constipation were evaluated with the Rome IV criteria. Key Results The prevalence of FI was 10.5% (n = 329) in the non‐comorbidity group. After multivariable logistic regression analysis, IBS (odds ratio [OR]: 12.55, 95% confidence interval [CI]: 9.06–17.36) and constipation (OR: 4.38, 95% CI: 3.27–5.85) were the most significant factors contributing to FI. Based on this finding, 106/329 (32.2%) had IBS‐associated FI, 119/329 (36.2%) had constipation‐associated FI, and 104/329 (31.6%) had isolated FI. Among the 329 FI respondents, there was a high prevalence of IBS and constipation‐related symptoms, including abdominal pain (81.5%) and abdominal bloating (77.8%) for IBS and straining during defecation (75.4%), incomplete defecation (72.3%), defecation blockage (63.2%), anal pain during defecation (59.3%), and hard stools (24%) for constipation. The patients with IBS‐associated FI asked for specialists' help less frequently than those with isolated FI. Interestingly, among the patients with constipation‐associated FI, 56.3% used anti‐diarrhea medicine. Conclusions and Inferences The prevalence of IBS‐associated FI, constipation‐associated FI, and isolated FI is comparably high. It is important to diagnose and target the cause of FI to provide personalized and cause‐targeting care instead of treating only the FI symptoms. The prevalence of IBS‐associated FI, constipation‐associated FI, and isolated FI is comparably high. It is important to diagnose and target the cause of FI to provide personalized and cause‐targeting care instead of treating only the FI symptoms.
ISSN:1350-1925
1365-2982
DOI:10.1111/nmo.14633